Fig. 1From: Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levelsDesign of the study. mg milligrams, OD once daily, R point of randomisationBack to article page